Insight Molecular Diagnostics Inc. (IMDX) earnings
Quarterly results of Insight Molecular Diagnostics Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Insight Molecular Diagnostics Inc. was expected to report around November 9, 2026; nothing is on file with the SEC yet.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Insight Molecular Diagnostics Inc. reported revenue of $239K (-53.9% on the same quarter a year earlier) and a net loss of $11.3M.
Diluted earnings per share were -$0.31.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | $239K | -53.9% | -$11.3M | -$0.31 |
| Q1 FY2026 | $32K | -98.5% | -$4.3M | -$0.12 |
| Q4 FY2025 | $1.1M | -23.4% | -$23M | - |
| Q3 FY2025 | $260K | +126.1% | -$10.9M | -$0.34 |
| Q2 FY2025 | $518K | - | -$9.7M | -$0.30 |
| Q1 FY2025 | $2.1M | - | -$6.7M | -$0.26 |
| Q4 FY2024 | $1.5M | - | -$33.5M | - |
| Q3 FY2024 | $115K | - | -$13.5M | -$0.98 |
Results filings
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
- Annual report 10-K
- Quarterly results 8-K
- Quarterly report 10-Q
When is Insight Molecular Diagnostics Inc.'s next earnings date?
Insight Molecular Diagnostics Inc. was expected to report around November 9, 2026; nothing is on file with the SEC yet.
What were Insight Molecular Diagnostics Inc.'s latest quarterly results?
For Q2 FY2026, which ended June 30, 2026, Insight Molecular Diagnostics Inc. reported revenue of $239K and a net loss of $11.3M. The figures come from its filing with the SEC.
Is Insight Molecular Diagnostics Inc.'s revenue growing?
Revenue in Q2 FY2026 was $239K, down 53.9% from $518K in the same quarter a year earlier.
Get an email when IMDX reports
Follow IMDX and we email you its next results the day they are filed, with the numbers explained.